Anesthesia and analgesia
-
Anesthesia and analgesia · Feb 2003
Clinical TrialEndotracheal intubation device with a charge couple device camera.
We developed an orotracheal intubation device equipped with a charge couple device (CCD) camera, providing a wide field of vision. We used this device to perform endotracheal intubations in 62 anesthetized patients undergoing dental treatment and oral surgery. The time required to perform an endotracheal intubation with this system was examined. ⋯ There were no significant differences in this procedure when the patients were grouped according to the Cormack and Lehane classification. There was no failure to intubate using this system. Because the device can extensively visualize not only the larynx, glottis, and vocal cords, but also the movement of the tube introducer, on the monitor screen via the CCD camera, endotracheal intubation can be easily performed while the vocal cords are visualized on the monitor screen.
-
Anesthesia and analgesia · Feb 2003
The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats.
In this study, we investigated whether the neuroprotection previously seen with dexmedetomidine or S(+)-ketamine involves regulation of proapoptotic (Bax and p53) and antiapoptotic (Bcl-2 and Mdm-2) proteins. Rats were anesthetized with isoflurane. After surgical preparation of isoflurane was discontinued, animals were randomly assigned to receive fentanyl and nitrous oxide (N(2)O)/oxygen plus 100 microg/kg of dexmedetomidine intraperitoneally 30 min before ischemia (n = 8), 1 mg x kg(-1) x min(-1) of S(+)-ketamine and oxygen/air (n = 8), or fentanyl and N(2)O/oxygen (n = 8; control group). ⋯ After cerebral ischemia/reperfusion, the relative protein concentration of Bax was increased by 110% in control animals compared with the dexmedetomidine- and S(+)-ketamine-treated rats and by 140% compared with the sham-operated animals. In animals treated with dexmedetomidine, the expression of Bcl-2 and Mdm-2 was larger compared with control (68% and 210%, respectively) or sham-operated (110% and 180%, respectively) animals. Therefore, it is possible that the neuroprotective properties of dexmedetomidine and S(+)-ketamine seen in previous studies involve ultra-early modulation of the balance between pro- and antiapoptotic proteins.
-
Anesthesia and analgesia · Feb 2003
Biography Historical ArticleThe contributions of A. W. Hofmann.